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Abstract: Ants (Formicidae) represent a taxonomically diverse group of hymenopterans with over
13,000 extant species, the majority of which inject or spray secretions from a venom gland. The
evolutionary success of ants is mostly due to their unique eusociality that has permitted them to
develop complex collaborative strategies, partly involving their venom secretions, to defend their nest
against predators, microbial pathogens, ant competitors, and to hunt prey. Activities of ant venom
include paralytic, cytolytic, haemolytic, allergenic, pro-inflammatory, insecticidal, antimicrobial,
and pain-producing pharmacologic activities, while non-toxic functions include roles in chemical
communication involving trail and sex pheromones, deterrents, and aggregators. While these diverse
activities in ant venoms have until now been largely understudied due to the small venom yield
from ants, modern analytical and venomic techniques are beginning to reveal the diversity of toxin
structure and function. As such, ant venoms are distinct from other venomous animals, not only rich
in linear, dimeric and disulfide-bonded peptides and bioactive proteins, but also other volatile and
non-volatile compounds such as alkaloids and hydrocarbons. The present review details the unique
structures and pharmacologies of known ant venom proteinaceous and alkaloidal toxins and their
potential as a source of novel bioinsecticides and therapeutic agents.
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1. Introduction
Nature contains a vast diversity of bioactive molecules and is hence a source of inspiration for
chemists, biochemists and the pharmaceutical industry searching for molecules of potential therapeutic
benefit or insecticidal activity. Amongst natural products, venoms are a promising source for the
discovery of unique molecules as they offer a formidable array of biological properties. Venoms are
complex cocktails of toxins that have been fine-tuned and pre-optimized during the course of evolution
for greater efficacy and target selectivity towards prey capture as well as defence against predators [1].
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Amongst venomous animals, insects represent a diverse group of organisms, with 120,000 extant
hymenopteran species [2].
Similar to other hymenopterans, ants (Vespoidea: Formicidae) have evolved a venom apparatus
that is derived from the ancestral reproductive system [3]. Ants are one of the most abundant groups
of venomous organisms and dominate most terrestrial environments [4,5], with around 13,165 extant
species described thus far [6] and an estimated total of ~25,000 species belonging to 16 different
subfamilies [7–9] (Figure 1A).
Their stunning ecological diversity has also contributed to broad species diversity and,
presumably, to the evolution of multiple venom types. For example, ground-dwelling ants of the
subfamilies Ponerinae and Myrmicinae contain venoms that are either used for generalist predation or
are specialized to prey on a locally abundant arthropod taxon (i.e., isopods, myriapods, collembolans
or termites). Ants that are restricted to one prey taxon and therefore may possess a specialist
venom include Psalidomyrmex procerus (Ponerinae), which preys only on earthworms, Strumigenys spp.
(Myrmicinae) which specializes in collembolan predation and Megaponera analis (Ponerinae), which
preys upon a limited number of termite species [10]. While many ants overcome their prey by attacking
in large numbers, some ant species are solitary hunters, suggesting that their venom is potent enough
to rapidly subdue their prey similarly to solitary wasps that specifically prey on caterpillars, crickets
or spiders [11].
This great taxonomical and ecological diversity has therefore allowed ants to employ their venom
for several purposes such as predation and defence against predators and competitors. It can also be
used for defence against microbial pathogens, communication, and as a herbicide [12–14]. Ant venoms
have been found to contain an extraordinary diversity of toxins and other types of molecules including
salts, sugars, formic acid, biogenic amines, alkaloids, free amino acids, hydrocarbons, peptides and
proteins [13,15–21]. However, due to the small size of these organisms, the amount of venom produced
by each ant is scarce in that some ants only produce around 10 µg or less of dry venom whilst other
ants are capable of producing up to 300 µg, compared to spiders, scorpions and snakes that produce
0.1–300 mg of dry venom per individual [22]. This has certainly contributed to the low number of
studies of ant venoms. Nevertheless, the present review aims to describe the current knowledge of the
wide range of toxins present in ant venoms and their functional roles.
2. Toxins from Non-Stinging Ants
Of all ant species, only 71% are considered to be stinging species due to the fact that a few ant
subfamilies have lost their ability to sting over the course of evolution. Instead of injecting their venoms,
Formicinae spray their venom (which is secreted by the venom gland), whereas Dolichoderinae and
Aneuretinae spray their targets with substances (i.e., ketones and iridoïds) secreted by their pygidial
glands [23]. Among the army ants (Dorylinae), ants from the genus Dorylus have a non-functional
stinger and their venom glands are a source of trail pheromones. Dorylus species do not employ venom
for prey immobilization but overcome their prey as a result of their overwhelming numbers (group
hunting behaviour) and their disabling bites (Figure 1A) [24].
While stinging species inject their secretions with a stinger, stingless ants from the subfamily
Formicinae spray their venoms through a special opening called the acidopore, a round orifice
surrounded by a fringe of hairs constituting a unique feature of formicine ants. The peculiarity
of this venom apparatus has considerably affected the chemical nature of the components secreted by
the venom glands, promoting the natural selection of volatile compounds. Formic acid (methanoic acid)
is the predominant compound and is presumably present in the venoms of all Formicinae, although
acetic acid can also be present [25]. Formic acid, present in concentrations of up to 70% (v/v), is an
alarm pheromone that, along with acetic acid, is an efficient defensive compound against competitors
and predators, including vertebrates [23,26]. The major precursors for its biosynthesis are the amino
acids serine and glycine [27]. By self-grooming their acidopore, Lasius neglectus (Formicinae) workers
uptake venom into their mouth and apply the acid on brood in their colony in order to inhibit the
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growth of fungal pathogens [25]. Also, upon occasional aggressive encounters, Nylanderia fulva
(Formicinae) workers can apply their formic acid-rich venom onto their cuticle to detoxify venom
alkaloids of the fire ant Solenopsis invicta (Myrmicinae) [28].Toxins 2016, 8, 30 
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Figure 1. Species diversity of ant veno pepti es. Panels A and B sho ata up ate fro
ili et al. 2014 [29]. (A) Ants have been grouped according to three clades, here L represe ts t e
si le- e s Leptanilloid clade. Stinging ants are represented by cyan bars and comprise around 71%
of all ant sp cies. Non-sti ing ant subfamilies ar depicted y brown bars. The total number of sp cies
in each subfamily is noted at the right of each bar. The newly escribed subfamily Dorylinae [7] is
composed of several junior synonyms including stinging ants that belong to the subfamilies i i ,
c yinae, Ecitoninae, Leptanillo dinae, and ants belo ing to the original subfamily Dorylinae
that lost the r ability to sting during ev lution. Also, it is unclear whet er the ants that once belonged to
the junior synonym subfamily Aenictogitoni ae, now subsumed in Dorylinae, are venomous or not, as
only males have been observe and fem les are yet to b described [30]; (B) Cumulative total number
of eptide-toxin s quences, showing th three main structural classes: cy n, linear peptides; brown,
dimeric peptides; red, ICK-like peptides. Ant venom peptides remain barely investigated, with only
75 p ptides sequenced to date; (C) Distribution of venom peptide structural classes by ant subfamily.
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Several arboreal ant species use their venom gland secretion as a herbicide to destroy plants,
mainly encroaching vines that compete with their host plant. An example of this is the Amazonian
species Myrmelachista schumanni (Formicinae) that creates the “devil1s gardens”—large stands of trees
almost exclusively comprised of Duroia hirsuta, a myrmecophyte sheltering M. schumanni colonies in
its hollow stems (domatia). Workers of this plant-ant species kill all trees situated around their host
plants with their venom, which is mostly composed of formic acid. This facilitates the growth and
establishment of their host plant [14,31].
3. Peptides
3.1. Ant Venom Peptides
In most animal venoms, peptides (<100 amino acids) are the predominant class of toxins and
have been investigated extensively in organisms such as scorpions, cone snails, and spiders [32–35].
Although ant venoms remain very much unexplored, recent studies have revealed that the venoms
of stinging ants (those belonging to the subfamilies Paraponerinae, Ponerinae, Amblyoponerinae,
Dorylinae, Myrmeciinae, Pseudomyrmecinae, Myrmicinae, and Ectatomminae) are also rich in
peptides, similar to other venomous animals [36,37]. To date, 75 venom peptides from only six
ant subfamilies (11 ant species) have been fully sequenced (Figure 1B) [29]. These peptides have
previously been classified based on their structure into three main groups: linear, dimeric, and inhibitor
cystine knot (ICK)-like peptides (for a complete review of ant venom peptides, see Aili et al. [29]). An
alternate approach to classifying ant venom peptides is to base the nomenclature on biological activity:
cytolytic and neurotoxic peptides. This review will address these ant venom peptides based on their
biological functions.
3.1.1. Cytolytic Peptides
Most proteomic studies on ant venoms have confirmed the prevalence of small, linear peptides
(devoid of disulfide bonds) with fewer than 35 residues [19,36,37]. Most of these small peptides
are cytolytic and often possess insecticidal, haemolytic and/or antimicrobial properties. Examples
include ponericins from the ant Neoponera goeldii (Ponerinae; formerly Pachycondyla goeldii) that
exhibit haemolytic activity, antibacterial activity against both Gram-positive and Gram-negative
bacteria, as well as insecticidal activity [12]. Ponericins have been classified into three different
families (“G”, “W”, and ”L”) based on sequence homology [29]. Numerous additional ponericin-like
peptides were also sequenced from the venom of Neoponera apicalis and N. inversa (Ponerinae; formerly
Pachycondyla apicalis and P. inversa) [38]. Thus, although the biological function of these peptides
has not been characterized, their strong homology to G-, W- and L-family ponericins from N. goeldii
suggests that they should have both antimicrobial and insecticidal activities, however, this remains to
be proven. Additional homologous toxins include dinoponeratoxins from both Dinoponera australis
and D. quadriceps (Ponerinae) [37,39], and bicarinalins from Tetramorium bicarinatum (Myrmicinae) [40].
Multiple alignment analyses have shown that these linear venom peptides display various degrees of
sequence homology to each other and that they can be separated into several families [41–44]. More
recently, three novel antimicrobial linear peptides with little homology to ponericin peptides have
been isolated from the venom of the ant Ectatomma brunneum (Ectatomminae; formerly known as
E. quadridens) [45].
Another group of peptides from ant venoms are pilosulins that constitute the major allergens of
the venom of Myrmecia pilosula (Myrmeciinae). Pilosulin 1 is a long linear peptide (57 amino acids)
and displays haemolytic and cytolytic activities [46,47]. Pilosulins 3, 4, and 5 are a group of homo-
and heterodimeric peptides. Although these peptides possess some antimicrobial activity, and are
classified as allergens, their biological function remains unknown [41,42].
The biological function of such membrane perturbing peptides in ant venoms is likely
to be varied. Among spider and scorpion venoms, cytolytic peptides are believed to act as
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membrane-disrupting agents, facilitating the passage of other disulfide-rich neurotoxins through
cellular barriers to their molecular targets [48]. These linear cytolytic peptides also have direct toxic
effects on prey, although this insecticidal activity is often moderate in comparison to disulfide-rich
neurotoxins [32]. However, in some cases, spiders and scorpions use cytolytic-based venoms rather
than neurotoxic-based venoms [49–51]. For example, the cyto-insectotoxins present in the venom of
the spider Lachesana tarabaevi have a potent insecticidal effect and are the major insecticidal toxins
in this venom [52]. Most ants seem to have evolved cytolytic-based venoms [12,36,37] and have
probably developed a strategy similar to that of the spider L. tarabaevi for subduing their prey. The
cytolytic peptides seen in most ant venoms act synergistically against different kinds of cells, disrupting
membranes and rapidly killing prey.
Due to their non-selective activity, membrane-perturbing venom peptides are able to target the
membranes of bacterial cells and, therefore, often exhibit some antimicrobial activity. This antimicrobial
activity may be a bonus function for ants as it helps with the social immunity of the colony [53,54].
In eusocial insects, promiscuity and the relative genetic homogeneity of individuals creates ideal
circumstances for the spread of infectious diseases in their nests. Therefore, the presence of multiple
membrane-perturbing peptides with antimicrobial activities in ant venoms is also believed to be a way
to disinfect captured prey before to bringing them back to the nest [12]. Another hypothetical function
would be to assist in pre-digestion of prey. This is important since adult ants only feed on liquids
due to their inability to digest solid food as a result of their narrow and constricted waists. Cytolytic
activity combined with an enzymatic activity would help the degradation of cellular membranes of
prey and, therefore, liquefy prey as do spider venoms [55].
Membrane-perturbing peptides are promising candidates for the future development of novel
antimicrobial, insecticidal, and anticancer drugs, and have been well investigated for this purpose for
many years. However, pharmaceutical research has struggled to find valid lead drug candidates as, to
date, these peptides cannot sufficiently discriminate between the membranes of pathogenic cells or
erythrocytes and other human host cells [48].
3.1.2. Neurotoxic Peptides
Neurotoxic peptides are widely expressed in animal venoms to assist in the rapid immobilization
of prey. These neurotoxins act on a broad diversity of molecular targets, mostly ion channels, with
varied selectivity, specificity, and efficacy. Many peptidic toxins modulating ion channels have been
discovered in arthropod venoms. As several ant venoms have paralytic effects on arthropods, it is
clear that they also contain neurotoxins that induce paralysis [11,56]. However, studies investigating
the neurotoxic properties of ant venom peptides are rare and only two neurotoxic peptides have been
characterized so far, as discussed below.
The first neurotoxic peptide that was isolated and characterized was poneratoxin, a small 25
residue linear peptide derived from the bullet ant Paraponera clavata (Paraponerinae). It has been shown
to be capable of modulating voltage-gated sodium (Nav) channels of both vertebrates and invertebrates,
blocking synaptic transmission in the insect CNS [57,58]. Poneratoxin causes repetitive firing and
prolongation of action potentials due to the presence of a slowly developing inward sodium current
that activates at hyperpolarizing potentials. This results from a potential toxin-induced interconversion
between a fast and a slow conducting state of the NaV channel [59–61]. Due to its high efficacy,
this peptide has been used in the construction of a novel bioinsecticide employing a recombinant
poneratoxin-producing baculovirus [61].
The other neurotoxic peptide isolated from ant venom is a dimeric peptide, Ectatomin Et-1,
from the ant Ectatomma tuberculatum which has been found to be the most potent neurotoxic peptide
isolated from ant venoms [62]. This peptide, which is one of a family of four related peptides from
Ectatomma spp., is a voltage-gated calcium (Cav) channel blocker, and also a pore-forming peptide
cytotoxic to vertebrate and invertebrate cells [63,64].
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3.1.3. Uncharacterized Peptides
Dimeric peptides are highly stable as they comprise two subunits that are linked by one
or several disulfide bonds. Among ant venoms, dimeric peptides seem to be common in the
formicoid subfamilies Ectatomminae, Pseudomyrmecinae, and Myrmeciinae (Figure 1C). In addition
to pilosulins and ectatomins, the myrmexins are a group of six heterodimeric peptides isolated
from the venom of Pseudomyrmex triplarinus (Pseudomyrmecinae) whose biological functions remain
unknown [65]. Homo- and heterodimeric peptides have also been shown to be present in the venoms
of P. penetrator [66] and Tetraponera sp. (Pseudomyrmecinae) [36] although their amino acid sequences
and biological activity also remain uncharacterized.
The recent transcriptome analysis of the venom glands of the giant ant Dinoponera quadriceps has
confirmed the sequence of a third structural class of ant venom peptides: the ICK-like peptides. ICK
peptides contain three disulfide bonds, forming a pseudo knot, and are very stable. These are present
in the venoms of cone snails and spiders, and typically have neurotoxic properties [67,68]. These
peptides are a minor component of the venom of the giant ant, and their role and biological activity is
still unknown [69].
Until recently, the limited amount of venom has restricted the biochemical characterization of ant
venom peptides. However, recent investigations using high resolution technologies to probe ant venom
peptidomes have revealed the vast and unexplored structural diversity of peptidic toxins with many
small, linear peptides as well as several peptides structured by disulfide bonds that constitute novel
structural classes of toxins with a likely novel, associated pharmacology [19,36,66]. Unfortunately,
the number of characterized ant venom peptides is vanishingly small compared with the enormous
peptide diversity revealed among ant venoms. This diversity, combined with the great ecological and
taxonomical diversity of ants, suggests that ant venom peptides constitute a promising new source in
the search for both novel drugs and insecticides.
3.2. Proposed Rational Nomenclature System for Ant Venom Peptides
Cutting-edge technologies such as integrated venomics represent a new gateway to exploring
the venom peptides of small organisms such as ants [70–72], and have led to increases in the rate of
description of novel peptidic toxins. Stinging ant venoms represent an untapped source of toxins,
and the total number of peptides has been estimated to be in excess of 1 million [36]. Thus far, there
is no consistent nomenclature for naming newly identified peptidic toxins in ant venoms. This may
cause considerable confusion, as presumably at some point there will be a surge of ant venom-derived
toxins being identified with the advent of new, more rapid and sensitive analytical strategies. It will
also be difficult to quickly compare toxins and establish evolutionary relationships with no consistent
nomenclature. The use of the same toxin name for different peptidic toxins with similar functions
regardless of the relatedness of the source ant species is advantageous, as it allows for the quick
identification of the peptide1s properties; however, it does not reveal any evolutionary relationships.
This is illustrated by the ponericins, a family of antimicrobial peptides, which were originally isolated
from three different species in the genus Neoponera (Ponerinae) [12,38] and later from the unrelated ant
Ectatomma brunneum (Ectatomminae) [45]. Another issue is the use of multiple names for the same
toxin, such as with Myr p 1, pilosulin 1, and Myr p 1.0101, where all names refer to the same peptide,
a linear allergenic peptide from the venom of Myrmecia pilosula [47,73]. Table 1 also highlights the
confusing similarity in the names of ant venom alkaloids vs. peptides (e.g., solenopsins vs. ponericins)
where toxins have completely different biochemical structure and function yet they are simply named
after the organism from which they were obtained.
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Table 1. Generic names for peptidic toxins from stinging ant subfamilies and their corresponding
abbreviations.














This highlights the unmet need for a standardized nomenclature system for ant venom peptides
in order to avoid confusion. Wiese et al. (2004) proposed a standardized nomenclature system for the
Myrmecia pilosula venom allergens according to the International Union of Immunological Societies
(IUIS) [74]. Although this system has been very useful for the pilosulins, it does not seem very practical
for the naming of all ant venom peptides. This is because it provides no details on the biological
activity or the molecular target of the toxin and it provides only minimal taxonomic information with
no reference to subfamilies. It is therefore of great importance to adopt a nomenclature with sufficient
detail and which follows the patterns of nomenclature used for other venomous organisms.
Accordingly, we propose adopting the standard nomenclature system used in naming spider [75],
centipede [76] and sea anemone venom peptides [77] for naming ant venom peptides. The
nomenclature is as follows:
i The toxin name should begin with a Greek letter prefix denoting the biological activity or
molecular target (if known) of the peptide; see King et al. for a summary [75]. Where the
target is not known the toxin should have a prefix of “U”. As only a few pharmacological
activities have been determined to date this will be an ongoing process. Haemolytic, cytolytic
or antibacterial peptides that have activity against bacteria, fungus, insect or vertebrate cells are
denoted by the Greek letter “M” to denote a general action to cause membrane perturbation.
Neurotoxic peptides (i.e., poneratoxin and ectatomin) which target voltage-gated sodium or
calcium ion channels have been identified by the prefixes “δ” and “ω”, respectively.
ii The Greek letter prefix will be followed by a generic toxin name. As all ants are grouped into
a single family (Formicidae), we propose to slightly modify King1s nomenclature which uses
family names and use the 13 extant stinging subfamily names instead (Figure 1A). This will allow
the toxins to be compared and will highlight the evolutionary relationship between different
toxins. A list of the proposed generic toxin names and their corresponding abbreviations
is proposed in Table 1 for all extant subfamilies of stinging ants. These names and their
abbreviations have been carefully chosen so that they do not overlap with current toxins from
other venomous animals nor other chemical groups. NB: non-stinging ants are thought to
contain mostly non-peptidic venom components, and are therefore not included.
iii The toxin name is then followed by an uppercase letter that indicates the genus of the ant and a
lowercase letter which identifies the species of the ant from which it was isolated. An additional
one or two lowercase letters may be required to distinguish species with the same first letters.
Due to several taxonomic revisions concerning ants, their species names are often subject to
modifications; therefore, all ant venom studies should follow the world1s largest online ant
database AntCat [6] when defining the most current species name.
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iv Finally, an alpha-numerical code will be used to separate different structural classes of peptides
based on their molecular scaffold and amino acid sequences. An Arabic numeral will be used to
distinguish different toxins from the same species with little amino acid homology or different
three-dimensional structures. A lowercase letter will also be added in order to distinguish
isotoxins. The isotoxins are named based on the sequence alignment analyses presented in the
review of Aili et al. [29]. The definition of isotoxin groups by Olivera et al. [77] will be used to
distinguish isotoxins. Toxins from the same ant species will be classified in the same isotoxin
group when there is ě 50% similarity in molecular size, biological function as well as amino
acid sequence.
We have applied this proposed nomenclature to all the known peptidic toxins isolated and
sequenced from the venoms of both poneroid (Table 2) and formicoid (Table 3) ants. Using this rational
nomenclature method, we have uniformly renamed the 75 currently sequenced peptidic ant toxins.
This new nomenclature will provide a clearer means of identifying and classifying former toxins as
well as new peptides, which will facilitate future exploration of ant venom peptides.
Table 2. Venom peptide toxins from poneroid ant species renamed according to the proposed rational
nomenclature system.
Species (Subfamily) Original Toxin Name Proposed Toxin Name Abbreviation Reference
Paraponera clavata
(Paraponerinae) Poneratoxin δ-Paraponeritoxin-Pc1a δ-PPOTX-Pc1a [57]
Neoponera goeldii
(Ponerinae)
Ponericin G1 M-poneritoxin-Ng3a M-PONTX-Ng3a [12]
Ponericin G2 U1-poneritoxin-Ng3b U1-PONTX-Ng3b [12]
Ponericin G3 M-poneritoxin-Ng3c M-PONTX-Ng3c [12]
Ponericin G4 M-poneritoxin-Ng3d M-PONTX-Ng3d [12]
Ponericin G5 U1-poneritoxin-Ng3e U1-PONTX-Ng3e [12]
Ponericin G6 M-poneritoxin-Ng3f M-PONTX-Ng3f [12]
Ponericin G7 U1-poneritoxin-Ng3g U1-PONTX-Ng3g [12]
Ponericin L1 U1-poneritoxin-Ng2a U1-PONTX-Ng2a [12]
Ponericin L2 M-poneritoxin-Ng2b M-PONTX-Ng2b [12]
Ponericin W1 M-poneritoxin-Ng1a M-PONTX-Ng1a [12]
Ponericin W2 U1-poneritoxin-Ng1b U1-PONTX-Ng1b [12]
Ponericin W3 M-poneritoxin-Ng1c M-PONTX-Ng1c [12]
Ponericin W4 M-poneritoxin-Ng1d M-PONTX-Ng1d [12]
Ponericin W5 M-poneritoxin-Ng1e M-PONTX-Ng1e [12]
Ponericin W6 M-poneritoxin-Ng1f M-PONTX-Ng1f [12]
Neoponera inversa
(Ponerinae)
Ponericin Pi I1 U1-poneritoxin-Ni3a U1-PONTX-Ni3a [38]
Ponericin Pi I2 U1-poneritoxin-Ni3b U1-PONTX-Ni3b [38]
Ponericin Pi I3 U1-poneritoxin-Ni3c U1-PONTX-Ni3c [38]
Ponericin Pi I4 U1-poneritoxin-Ni3d U1-PONTX-Ni3d [38]
Ponericin Pi II1 U1-poneritoxin-Ni1a U1-PONTX-Ni1a [38]
Ponericin Pi II2 U1-poneritoxin-Ni1b U1-PONTX-Ni1b [38]
Ponericin Pi III1 U1-poneritoxin-Ni2a U1-PONTX-Ni2a [38]
Neoponera apicalis
(Ponerinae)
Ponericin Pa I1 U1-poneritoxin-Na3a U1-PONTX-Na3a [38]
Ponericin Pa I2 U1-poneritoxin-Na3b U1-PONTX-Na3b [38]
Ponericin Pa II 1 U1-poneritoxin-Na1a U1-PONTX-Na1a [38]
Ponericin Pa II 2 U1-poneritoxin-Na1b U1-PONTX-Na1b [38]
Ponericin Pa IV1 U1-poneritoxin-Na2a U1-PONTX-Na2a [38]
Dinoponera australis
(Ponerinae)
Dinoponeratoxin Da-1039 U1-poneritoxin-Da1a U1-PONTX-Da1a [39]
Dinoponeratoxin Da-1585 U1-poneritoxin-Da3a U1-PONTX-Da3a [39]
Dinoponeratoxin Da-1837 U1-poneritoxin-Da2a U1-PONTX-Da2a [39]
Dinoponeratoxin Da-2501 U1-poneritoxin-Da3b U1-PONTX-Da3b [39]
Dinoponeratoxin Da-3105 U1-poneritoxin-Da4a U1-PONTX-Da4a [39]
Dinoponeratoxin Da-3177 M-poneritoxin-Da4b M-PONTX-Da4b [39]
Dinoponera quadriceps
(Ponerinae)
Dinoponeratoxin Dq-762 U1-poneritoxin-Dq1a U1-PONTX-Dq1a [37]
Dinoponeratoxin Dq-987 U1-poneritoxin-Dq1b U1-PONTX-Dq1b [37]
Dinoponeratoxin Dq-1031 U1-poneritoxin-Dq1c U1-PONTX-Dq1c [37]
Dinoponeratoxin Dq-1062 U1-poneritoxin-Dq2a U1-PONTX-Dq2a [37]
Dinoponeratoxin Dq-1133 U1-poneritoxin-Dq2b U1-PONTX-Dq2b [37]
Dinoponeratoxin Dq-1289 U1-poneritoxin-Dq2c U1-PONTX-Dq2c [37]
Dinoponeratoxin Dq-1839 U1-poneritoxin-Dq3a U1-PONTX-Dq3a [37]
Dinoponeratoxin Dq-1840 U1-poneritoxin-Dq3b U1-PONTX-Dq3b [37]
Dinoponeratoxin Dq-1856 U1-poneritoxin-Dq3c U1-PONTX-Dq3c [37]
Dinoponeratoxin Dq-1897 U1-poneritoxin-Dq3d U1-PONTX-Dq3d [37]
Dinoponeratoxin Dq-1984 U1-poneritoxin-Dq3e U1-PONTX-Dq3e [37]
Dinoponeratoxin Dq-3104 M-poneritoxin-Dq4a M-PONTX-Dq4a [37]
Dinoponeratoxin Dq-3162 M-poneritoxin-Dq4b M-PONTX-Dq4b [37]
Dinoponeratoxin Dq-3163 U1-poneritoxin-Dq4c U1-PONTX-Dq4c [37]
Dinoponeratoxin Dq-3178 U1-poneritoxin-Dq4d U1-PONTX-Dq4d [37]
Dinoponeratoxin ICK-like U1-poneritoxin-Dq5a U1-PONTX-Dq5a [69]
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Table 3. Venom peptide toxins from formicoid ant species renamed according to the proposed rational
nomenclature system.
Species (Subfamily) Original Toxin Name Proposed Toxin Name Abbreviation Reference
Tetramorium bicarinatum
(Myrmicinae)
Bicarinalin 1 M-myrmicitoxin-Tb1a M-MYRTX-Tb1a [40]
P 17 U1-myrmicitoxin-Tb2a U1-MYRTX-Tb2a [40]
Ectatomma tuberculatum
(Ectatomminae)
Ectatomin-Et1 ω/M-ectatotoxin-Et1a ω/M-ECTX-Et1a [62]
Ectatomin-Et2 U1-ectatotoxin-Et1b U1-ECTX-Et1b [78]
Ectatomma brunneum
(Ectatomminae)
Ectatomin-Eq1 U1-ectatotoxin-Eb1a U1-ECTX-Eb1a [78]
Ectatomin-Eq2 U1-ectatotoxin-Eb1b U1-ECTX-Eb1b [78]
Ponericin-Q42 M-ectatotoxin-Eb2a M-ECTX-Eb2a [45]
Ponericin-Q49 M-ectatotoxin-Eb2b M-ECTX-Eb2b [45]
Ponericin-Q50 M-ectatotoxin-Eb2c M-ECTX-Eb2c [45]
Pseudomyrmex triplarinus
(Pseudomyrmecinae)
Myrmexin I U1-pseudomyrmecitoxin-Pt1a U1-PSDTX-Pt1a [65]
Myrmexin II U1-pseudomyrmecitoxin-Pt1b U1-PSDTX-Pt1b [65]
Myrmexin III U1-pseudomyrmecitoxin-Pt1c U1-PSDTX-Pt1c [65]
Myrmexin IV U1-pseudomyrmecitoxin-Pt1d U1-PSDTX-Pt1d [65]
Myrmexin V U1-pseudomyrmecitoxin-Pt1e U1-PSDTX-Pt1e [65]
Myrmexin VI U1-pseudomyrmecitoxin-Pt1f U1-PSDTX-Pt1f [65]
Myrmecia pilosula
(Myrmeciinae)
Myr p 157–112 M-myrmeciitoxin-Mp1a M-MIITX-Mp1a [79]
Myr p 1 57–112 (Ile5) M-myrmeciitoxin-Mp1b M-MIITX-Mp1b [79]
Myr p 1 65–112 M-myrmeciitoxin-Mp1c M-MIITX-Mp1c [79]
Myr p 1 68–112 M-myrmeciitoxin-Mp1d M-MIITX-Mp1d [79]
Myr p 1 71–112 M-myrmeciitoxin-Mp1e M-MIITX-Mp1e [79]
Myr p 1 86–112 U1-myrmeciitoxin-Mp1f U1-MIITX-Mp1f [79]
Pilosulin 3a M-myrmeciitoxin-Mp2a M-MIITX-Mp2a [41]
Pilosulin 3b M-myrmeciitoxin-Mp2b M-MIITX-Mp2b [41]
Pilosulin 4 M-myrmeciitoxin-Mp3a M-MIITX-Mp3a [41]
Pilosulin 5 M-myrmeciitoxin-Mp4a M-MIITX-Mp4a [42]
4. Ant Venom Proteins
Although ants are amongst the most abundant and diverse of all social insects [5], there remains
limited information in the literature regarding their venom protein characteristics. Most published
studies have investigated the allergenic properties of ant venoms [43,74,80]. This is especially true
for proteomic data, even though such information can give insights into the functions of venom
components [81]. This paucity of data is mainly due to the limited amount of venom that can be
obtained from stinging ants [82] and the laborious nature of venom dissections and extractions [83,84].
Nevertheless, current data shows that ant venom proteins are highly diverse, as is the case with
the peptide component. This diversity is further exemplified with the vastly different patterns of
venom protein expression across ant subfamilies which has been attributed to both phylogenetic and
behavioural differences between ants [82,85].
One of the first studies to report the presence of proteins in ant venoms was that of Leluk et al. [81]
which found proteins ranging from 24 to 75 kDa in all six ants investigated (Dinoponera grandis,
Diacamma sp., Paraponera clavata, Odontoponera transversa, Pogonomyrmex rugosus, and Po. maricopa).
The two most investigated ants using proteomics are Myrmecia pilosula (Australian jack jumper ant)
and Solenopsis invicta (red imported fire ant) due to frequent allergic reactions to their sting which
can lead to anaphylaxis and, in some extreme cases, death [83,85]. In fact, the first ever published
study proving the presence of proteins in ant venoms was performed on the red imported fire ant in
1979, where the authors managed to extract and enzymatically assay venom proteins by employing
chromatographic separation on a massive amount of manually-milked venom (ca. 120 mg) [86].
Myrmecia pilosula venom is mainly composed of peptides, however, it does contain six proteins
between 26 and 90 kDa [43,74]. Most of its activity was originally attributed to the pilosulin peptides
(see Section 3.1.1), however, it was later found that the proteins also play a role in the allergic
reactions [43,74,80,87]. An interesting feature of this venom, which had hindered investigations of its
composition in the past, is its highly basic nature which makes venom proteins more difficult to separate
based on isoelectric point (pI) when using two-dimensional polyacrylamide gel electrophoresis
(2D-PAGE) [80]. The basic nature of these venom proteins is common with defensive venoms, such as
that of bees, and the proteins responsible for this effect usually cause painful or cytolytic effects [81].
However, this is not common amongst ants, as the original study performed by Leluk et al. (1989)
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revealed that the majority of the six ants investigated contained acidic venoms, particularly that of
Paraponera clavata [81].
The proteome of Solenopsis invicta has only recently been investigated using 2D-PAGE based on a
commercial protein extract, due to the small amount of protein present in the venom in comparison to
its high alkaloid content (>95% alkaloids; see Section 5.2) [74,84,88]. It has been postulated that one
reason for S. invicta venom being less proteinaceous than those of other ant venoms is that this ant
evolved more recently compared to the more ancestral ants with higher venom protein content [89].
Other venoms that have been shown to be proteinaceous in nature are those from Ponerinae, Dorylinae,
Pseudomyrmecinae (e.g., Pseudomyrmex triplarinus with proteins making up 42% of the venom1s dry
weight [90]), and even some Myrmicinae such as Myrmica spp. and Pogonomyrmex spp.
The proteins identified in ant venoms have been assigned to one of the following three major
functional protein groups: housekeeping proteins, body muscle proteins, or true venom proteins
(classification modified from [83]). Previous transcriptomic studies have revealed that the majority of
transcripts identified from the venom glands (~40%–65%) are housekeeping proteins such as ribosomal
proteins which come from the venom gland tissues [69,85,87]. These predicted housekeeping and
body muscle proteins have also been predicted by other approaches such as proteomics [83] and are
therefore not covered in this review as they are not true venom components. Transcriptomics has
revealed that true venom proteins make up a small fraction of the transcripts being expressed in venom
gland tissues (<1%–5%).While there are indications of several new venom gland components using
transcriptomics, one must be cautious in considering that not all potential transcripts identified are
necessarily translated into proteins, and must be confirmed using proteomic techniques. Therefore,
true venom components which have been confirmed by proteomic studies have been categorized into
(1) toxic venom proteins; (2) non-toxic proteins involved in protecting other venom components and
the gland tissue; and (3) non-toxic proteins involved in chemical communication.
4.1. Toxic Venom Proteins
The present review will discuss those proteins which have been associated with venom diffusion
and toxicity to prey or predators as well as major allergenic proteins revealed by venom gland
proteomic and transcriptomic studies. These proteins can be further classified into five subgroups:
(1) neurotoxins; (2) proteins that promote venom diffusion or modulate prey defense mechanisms;
(3) proteins that promote tissue damage or cause inflammation; (4) allergens; and (5) antimicrobial
proteins involved in colony/food asepsis. Ant venom toxic proteins commonly interfere with tissue
signalling, lipid homeostasis, protein–protein interactions or trafficking of vesicles [69]. While only
two ant venom gland transcriptomes have been published to date, these have revealed an enormous
amount of novel information regarding potential proteins in the venom gland [69,85,91]. It is clear that
further transcriptomic studies are necessary, as it would make the current difficult task of novel protein
annotation a lot clearer [83]. Moreover, a significant number of predicted proteins are apparently
unique to ant venoms, as they are not homologous to previously deposited sequences in databanks
from other tissues or organisms for the first time [69,85,91].
4.1.1. Neurotoxic Proteins
An increasing number of proteins that cause neurotoxicity are being revealed in ant venoms.
For example, the proteomic investigation of Solenopsis invicta venom [83] revealed the presence of
three 18–43.1 kDa neurotoxins similar to proteins from other arthropods. One of these proteins is
homologous to U5-ctenitoxin-Pk1a-like protein which has been implicated in causing spastic paralysis
in mice [92]. The other protein found is homologous to the neurotoxic alpha-toxin Tc48a-like protein,
which is also lethal to mice through its action on NaV channels [83,93]. The third neurotoxic protein
was homologous to Scolopendra (Chilopoda) toxin-like proteins which are not lethal to vertebrates, but
are neurotoxic to insects and crustaceans [94,95].
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Phospholipases have been described as one of the major proteins in several hymenopteran venoms
and are considered potent neurotoxic, cytotoxic and allergenic proteins [82,96]. Phospholipases (PL)
hydrolyze the different ester linkages in phospholipids. There are five major types: PLA1, PLA2,
and PLC (which cleave ester bonds at positions sn-1, sn-2, and sn-3, respectively), PLD (which is
mainly found in plants that attacks the nitrogenous base of the phospholipids) and PLB (which
cleaves lysophospholipids) [96]. The most commonly reported phospholipase in ant venoms is
PLA2 [83,97–99], however, there have been isolated reports of PLA1, PLB, and PLD as well [69,99,100].
Venom phospholipases from various animals have been demonstrated to induce neurotoxicity, platelet
activation, allergic reactions, haemolysis, and tissue damage. Unlike snake venom phospholipases
which are lethal to their prey [69,101], ant venom phospholipases have not been implicated in causing
lethality of prey, however, it is likely that they have synergistic activity with other toxic proteins which
cause lethality [83,102].
4.1.2. Proteins that Promote Venom Diffusion or Modulate Victim Defense Mechanisms
Examples of proteins involved with tissue damage would include phospholipases, hyaluronidases,
proteases, and venom acid phosphatases. Hyaluronidase is implicated in aiding the spread of venom
through the host tissues. This results from the hydrolysis of hyaluronic acid and chondroitin sulphate
which are essential components of connective tissues [82], thereby increasing membrane permeability,
reducing viscosity, and making tissues more permeable to venom neurotoxins [82,103]. This function
has been used clinically to assist in the absorption of fluids administrated by subcutaneous or
intramuscular injection, and to improve the diffusion of local anaesthetics [82]. Hyaluronidase
activity was observed in all nine ant venoms tested by Schmidt et al. [102], however, the activity was
lower in comparison to that observed in wasp venoms. The ants with the highest hyaluronidase
activity were the tropical ants Paraponera clavata and Ectatomma tuberculatum [102]. Other ants
which have been found to contain hyaluronidase activity in the venom are Myrmecia pyriformis [104],
Pseudomyrmex triplarinus [90] and Solenopsis invicta [86].
Proteases are responsible for moderate necrosis in some tissues of patients following
envenomation by various venomous animals. Little information is available on venom proteases
in insects, especially in ant venoms [82], and clinical reports of necrosis from ant stings are likely a
result of secondary bacterial infections [60]. However, proteases have been reported in Eciton burchellii
in very high levels [102]. Transcriptomic analysis of the venom gland of the ant Tetramorium bicarinatum
suggested that the main toxin-like proteins are metalloproteinases that degrade proteins and hydrolyse
specific peptide bonds [85]. The presence of a metalloproteinase in ant venom is significant as they
are thought to be involved in disruption of the host1s coagulation cascade as well as in generating
a more digestible prey [85]. A metalloproteinase has also been found in the venom of the fire ant
Solenopsis invicta using proteomics techniques [83]. In wasps, metalloproteinases have been associated
with inflammation, necrosis, oedema, and skin damage after massive attacks on humans [83].
Other proteases which have been identified in several hymenopterans and some ants are
carboxylesterases [69,105]. These enzymes hydrolyse carboxylic acid esters into acids and alcohols;
this enzyme has been considered to have a protective function for the organism as it promotes cellular
detoxification by inactivating carcinogens and toxicants. Pesticides and drugs usually contain ester
moieties that are susceptible to these enzymes and are therefore degraded by this enzyme. This
enzyme has been found in the genomes of the ants Harpegnathos saltator, Camponotus floridanus,
Acromyrmex echinatior [106], and, more recently, in Dinoponera quadriceps through transcriptomic
analysis [69].
Another interesting finding of the investigation by Schmidt et al. [102] was the presence of
phosphodiesterase activity in the venom of the ants Ectatomma tuberculatum and Paraponera clavata.
Phosphodiesterases are more common in snake venoms and have not yet been reported in insect
venoms [102,107]. They have been associated with catalysing the action of other active or toxic venom
component functions [102] which can cause cell lysis or DNA/RNA degradation in the prey [107].
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Several enzymes potentially involved with targeting major host defence cascades were also
revealed through transcriptomics analysis of Tetramorium bicarinatum venom [85,91]. An example
of such a protein is phenoloxidase which is a multicopperoxidase which generates highly reactive
and toxic quinine intermediates that clear bacterial infections from the insect. This is because they
cross-link bacteria to a protein on the cytoplasmic membrane of haemocytes [108,109]. This protein
has been identified as an important venom compound among parasitic wasps to disrupt their host1s
immune systems.
4.1.3. Proteins that Promote Tissue Damage or Cause Inflammation
Phospholipases are a common protein found in ant and other hymenopteran venoms that, in
addition to the activities described in Section 4.1.1, cause disruption of the phospholipid membrane
leading to pore formation, inflammation, and cell lysis [83,110,111]. One of the earliest reports of
phospholipase activity in ant venoms was in the bulldog ant Myrmecia pyriformis [112]. However,
since then many other ants have been reported to express phospholipases in their venom either
through enzymatic, proteomic or transcriptomic studies. For example, the ants Paraponera clavata,
Pogonomyrmex occidentalis, Pogonomyrmex badius, Eciton burchellii [102], Pseudomyrmex triplarinus [90],
Dinoponera grandis, Solenopsis invicta, and Ectatomma tuberculatum [96] have all been reported to have
phospholipase activity using enzymatic studies. Through transcriptomic techniques, the additional
ant species Dinoponera quadriceps [69] and Tetramorium bicarinatum [91] have also been reported to
have phospholipases. According to current data, the phospholipase activity of ant venoms seems to
be lower than that of wasps. While the activity of Pogonomyrmex badius is comparable to that of the
yellow jacket wasp [102], Tetramorium caespitum has with no reported phospholipase activity [89]. This
indicates that venom phospholipase activity is not broadly distributed in all ant species.
As previously mentioned, PLDs have not been reported in hymenopteran venoms, however they
have been recently predicted in two ant venoms, Dinoponera quadriceps and Solenopsis invicta [69,83].
The presence of PLD in ant venoms is a significant finding as it has only been previously reported
in spider venoms, highlighting the need for confirmation by enzymatic assays. The enzyme has
been often referred to as sphingomyelinase D where it can hydrolyze sphingomyelin containing
membranes, or phospholipase D by virtue of its wider spectrum of lipid substrates. In the brown
spider Loxoceles gaucho, sphingomyelinase activity results in characteristic dermonecrotic lesions, which
typically follow a massive inflammatory response [113,114].
The 2D-PAGE analysis of Solenopsis invicta [83] revealed the presence of several other proteins
that could promote tissue damage. These included myotoxin 2-like proteins previously found in
snake venom proteins that have been reported to cause necrosis of tissue by increasing cytolysis and
microvascular permeability [83,115] and PSTx 60-like protein previously identified from sea anemones
which also promotes tissue damage due to a haemolytic action [116].
Venom acid phosphatases are common toxic inflammatory enzymes in venoms and have known
digestive functions and toxic actions to cause histamine release and cell lysis [117,118]. Venom
acid phosphatases also seem to be common in ant venoms in different levels of abundance, with
Eciton burchellii and Ectatomma tuberculatum having the highest reported activity [98,102]. Interestingly,
ants have higher activities of this enzyme overall compared to wasp venoms [102]. This enzyme is also
a typical tissue enzyme, so it has been suggested that it might be a contamination from the venom
gland tissues. However, venom collected by electrical stimulation was found to contain these proteins
suggesting this is a true venom protein [102].
4.1.4. Allergens
An allergen is any substance capable of eliciting an allergic reaction. Often, this can culminate
in anaphylactic shock, which is a serious reaction involving oedema and systemic smooth muscle
stimulation. The autacoid histamine is one of the key molecules involved in the mediation of
hypersensitivity. Whilst all known allergens are relatively large molecules, with most allergens
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consisting of proteins or protein conjugates, the exact chemical properties leading to allergenicity
are not well understood. There are also other substances which can induce the release of histamine,
potentially leading to a hypersensitive state. In summary, (i) different families of proteins may work as
potent allergens, although this cannot be reliably predicted from their sequence, nor does it depend on
enzymatic activity; and (ii) some enzymes and non-proteinaceous substances can induce histamine
release, either directly or by activating the immune system via local reaction products, thus also acting
as allergens.
Allergic reactions, as well as anaphylaxis, are a common manifestation of stings by species of the
order Hymenoptera, and ants are no exception. Indeed, it has been reported that perhaps over 50% of
venom secretion proteins are allergenic proteins [85]. In Australia, most allergic reactions to ants are
attributed to ants of the genus Myrmecia, particularly the jack jumper ant Myrmecia pilosula [43,74,80].
This ant has been alleged to rival the fire ant Solenopsis invicta in terms of venom allergenicity. Within
hymenopterans, proteins ranging from 20 to 50 kDa are usually the source of these allergenic effects [80].
However, up until fairly recently, most allergenic activity was attributed to the peptide components.
For example, M. pilosula allergenicity was mainly attributed to the pilosulins, however, seven proteins
(20–90 kDa) have now been discovered and are believed to contribute to the allergic effects manifested
after a sting [74,81].
An example of an ant whose allergenicity was attributed to proteins is that of Solenopsis invicta
whose four main allergens (Sol i 1–4) are between 14 and 37 kDa [98,99,119–121]. Initially, it was
believed that they all possessed phospholipase activities which was causing the allergenic effects [98],
due to previous work suggesting that phospholipases cause the release of histamine [104]. A
pioneering study on these allergens using enzymatic assays ruled out hyaluronidases and venom acid
phosphatases as the cause of the allergenic effects of fire ant venoms [98]. To date, little is known
about the biological activities of most of these proteins. Sol i 1 contains both phospholipase A1 and B
activity and was shown to be more related to vespid phospholipases than bee phospholipases [83,99].
Sol i 2 has had its crystal structure recently determined (see Figure 2) [119,122], and was suggested to
play a role in binding temporarily to hydrophobic factors such as trail pheromones [122]. Sol i 3 is a
dimeric protein that is a member of the antigen 5 protein family with no known enzymatic activity (see
Figure 3) [83,123–125]. Sol i 4 is homologous to Sol i 2 in sequence but occurs as a monomer [122] its
biological function is also still unknown. Like Sol i 2, it is unique to ant venoms and does not seem to
be homologous to any bee or vespid proteins [83,124]. Further potential allergens have been recently
identified among fire ant venom proteins, which proved to be more diverse than previously thought,
however specific immunological tests are necessary to confirm which ones are the most allergenic
proteins [83]. Homologs of Sol i 2 and Sol i 3 have been predicted from the transcriptome of Dinoponera
quadriceps, however, they have several unique amino acids which show species-specific diversification
of these proteins [69].
Brachyponera chinensis (formerly Pachycondyla chinensis) is another ant whose proteins account for
the majority of the allergic manifestations. Thus far, nine proteins (all >10 kDa) have been identified as
allergenic using 2D-PAGE and western blots. The major allergenic protein seems to be a 23 kDa protein
with a pI 8.7 given that the majority of IgE proteins from hypersensitive patients reacted against this
protein. This protein was found to be homologous to Solenopsis invicta Sol i 3 and the antigen 5 family
of proteins [124].
4.1.5. Antimicrobial Proteins
Antimicrobial proteins have bactericidal activity and include proteins with a colony asepsis
role, preventing contamination of stored food as well as colony individuals, including the brood.
An interesting group of proteins involved with colony asepsis from Solenopsis invicta venom are the
bactericidal transferrins [83]. These proteins chelate free Fe3+ in biological fluids, making it unavailable
for use by bacteria that need it for their survival [126].
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Figure 3. Crystal structure of the fire ant (Solenopsis invicta) venom allergen Sol i 3 dimer (PDB accession
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sequence searches. Such proteins could include unique venom toxins that could be investigated as
potential insecticidal or antimicrobial drugs.
5. Ant Alkaloids
Alkaloids are defined as a heterogeneous assembly of secondary metabolite cyclic compounds
containing nitrogen atoms in a negative oxidation state [127]. Nowadays, around 14,000 different
alkaloids are known [127] with the inevitable result that the chemistry of alkaloids is very complex with
numerous chemical subdivisions. They are primarily found in plants, particularly in the Angiosperma,
where alkaloid production pathways seem to have diversified mainly as a protection against defoliation
by herbivores [128]. However, it is not only plants that contain alkaloids, with a number of alkaloids
having been isolated from fungi, and different classes of vertebrates (e.g., numerous toads, the musk
deer, and beavers) and invertebrates (mainly marine sponges, myriapods, and insects). Alkaloid-rich
insects are particularly prevalent among lepidopterans, beetles, and ants [129].
Alkaloids in ants were first reported in the early 1970s [130] and they have been reported in an
increasing number of different ant groups, particularly as venom secretions (for a summary see Table 4).
Although wasp venoms may contain amines and several other low molecular weight compounds,
venom alkaloids seem to be a particularity of ants within Hymenopterans [127,131].
Table 4. Ant genera containing venom alkaloids.
Subfamily Ant Genus Structural Family Trivial Name Reference
Myrmicinae
Atta Acromyrmex Pyrroles Trail pheromone [132]
Messor Pyridines Anabaseine Anabasine [133,134]





















Carebarella 1 Pyrrolidines HistrionicotoxinsGephyrotoxin [142]
Leptothorax
Harpagoxenus Alkylpyrrolidines – [143]
Formicinae NylanderiaBrachymyrmex Alkyl-hydroxyl-indolizidines Pumiliotoxins
2 [144]
Pseudomyrmecinae Tetraponera Pyrimidines Tetraponerines [145]
1 This genus has been very recently incorporated within Solenopsis [146]; 2 Pumiliotoxins are important alkaloids
isolated from mixed whole ant extracts of other groups, but as yet it is unknown whether these alkaloids come
from the venom apparatus.
In the following sections, only alkaloids with toxic activities found in ant venoms are discussed;
for an overview of general alkaloid structures and classification see Anisewiski [127]. Ant alkaloids can
be either monocyclic, bicyclic, tricyclic or polycyclic (the latter being derived from tricyclic alkaloids),
thus displaying considerable diversity (Figure 4). The venom from ants of the same species group may
contain several different alkaloids and isomers, however they all tend to share the same basic structure
(exemplified by the alkaloids from the venom of fire ant workers in Figure 5). Venom alkaloids in
ants, particularly in those groups where they are predominant compounds, play a central role in
their biology.
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GC-MS chromatogram of hexane solvent in which fire ant workers were immersed.
5.1. Production of Alkaloids in Ant Venoms
As previously mentioned, most alkaloids are primarily described from plant extracts, illustrated
by the well-studied compounds coniine and nicotine. Plants take advantage of secondary metabolites,
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such as alkaloids, as a deterrent against herbivores. Therefore, it is often presumed that ants can
sequester alkaloids into their venoms by feeding on plants [147], however, laboratory ant colonies can
produce alkaloids in the absence of such foods, thus demonstrating they synthesize the compounds
directly (personal observation by EGPF). This observation singles out ants, from other hymenopterans,
for their capacity to produce copious amounts of bioactive alkaloids, with different groups of ants
producing particular groups of alkaloids (Table 4). Venom alkaloids are believed to be produced
inside the convoluted gland of the venom apparatus, as mentioned in anatomical studies of the venom
apparatus of Solenopsis fire ants [148,149]. These authors even demonstrated local tissue damage
possibly caused by synthesis and storage of such toxic compounds. Exactly how these ants produce
the alkaloids is presently unknown, however, a few biochemical pathways have been proposed [150].
Interestingly it has been mentioned that among the transcripts of a fire ant venom gland, there
are several enzymes related to the mevalonate pathway of synthesis of polyketides, which is the
biochemical pathway attributed to this class of alkaloids [20]. It is also possible that a microbial
symbiont may have been involved in the production of intermediary compounds, as was suggested
for some alkaloids found in sponges [151] and briefly hinted at in ants by Saporito et al. [144].
To date, alkaloids are known to be prominent within the venom secretions of the subfamily
Myrmicinae, particularly within the tribe Solenopsidini, which includes such genera as Solenopsis,
Monomorium, Allomerus, and Megalomyrmex. These ants usually either infest the nests of other species
(e.g., thief ants within Solenopsis and Megalomyrmex) or they are slow-moving hardy foragers such as
the flower ants from the genus Monomorium. Alkaloids are usually bitter and frequently poisonous
when ingested, thus these ants are granted protection against most potential predators. Moreover,
venom alkaloids aid these ants to manipulate and avoid their host species and competitors.
The literature concerning the biological activities of alkaloidal compounds detected in ant venoms
is fragmented. Ant alkaloids have only been investigated in a minority of ant species where they are
associated with a range of biological activities, with different activities often reported for the same
compounds across different ant groups. Nevertheless, several alkaloids detected in ants are shared
with other distant organisms (e.g., anabaseine alkaloids are also found in nemertine worms, and
tobacco plants), and a few have been synthesized for specific investigations (e.g., synthetic solenopsins
for biomedical studies). In such instances, there are studies of their chemical and biological properties
published in sources unrelated to myrmecology (see Anisewiski [127]). Non-toxic activities include
those relating to communication and behavioral modulation including trail, alarm and sex pheromones
and attractants [131,152] but these are outside of the scope of this review and will not be covered here.
For a more complete overview on the biological activities of ant venom alkaloids, please refer to Jones
& Blum 1983, Brossi 1987, Escoubas & Blum 1990, Anisewisky 2015 [127,153–155].
Alkaloids with toxic adverse effects on other organisms include: (i) herbicidal effects recorded
from the alkaloid-rich venom of Solenopsis [153]; (ii) arthropod toxins that are used against competitors,
predators, and prey either by spraying, injection or topical application, mainly recorded from
Monomorium, Solenopsis, and Tetraponera; (iii) antimicrobials which remain to date poorly studied
in ant venoms excepting studies with Solenopsis and some tests with Monomorium; and (iv) mammalian
toxins, as demonstrated by tests on mammals and mammalian cells, reported mainly from Solenopsis,
but also from Monomorium and Tetraponera [156]. Considering the disproportionate number of studies
regarding the toxic effects of fire ant venom alkaloids, they are discussed in further detail below.
5.2. Solenopsins: A Case Study of Ant Venom Alkaloids
The chemistry and physiological effects of venom alkaloids have been best studied among the
fire ants (Solenopsis spp.; Myrmicinae), a notable group of about 20 species [157]. Compared to other
Solenopsis ants which typically behave as thief-ants, fire ants are much larger and faster, foraging
in the open and using venom to subdue larger prey, defend their ground and food, and discourage
predators. They are widely reputed for their aggressiveness combined with the burning sensation
caused by their stings [157]. When injected into the skin their poorly-soluble venom alkaloids cause a
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local inflammatory reaction, and can lead to pustule formation within hours. Due to some fire ants
being regarded as one of the top-rated global invasive pests, there is a growing body of literature about
their biology and venom alkaloids.
5.2.1. Solenopsin Chemistry
Alkaloids in fire ant venoms are mainly hydrophobic piperidines called solenopsins (generally
similar in structure to coniine and nicotine [127]) and piperideines in much lesser amounts. These are
oxygen-free polyketide alkaloids as their nitrogen atom is inserted into a polyketide carbon skeleton,
and they are not metabolically derived from amino acids [127]. Structurally, these are compounds
with a piperidinic ring, often unsaturated, attached to the side by a hydrocarbon chain of variable
length [127] (Figure 2). The solenopsins come in many isomeric forms with slightly different chemical
and biological properties for each configuration [158]. There are several piperideines found in trace
amounts in the venom, which are currently thought to be unstable intermediates for the synthesis of
solenopsins, but these remain largely unstudied [158].
The solenopsins can be easily extracted from Solenopsis ants either by directly dissecting the
venom glands or by dipping the ants in organic solvents [21,159]. The extract can then be partially
purified through traditional thin-layer or silica column chromatography based on the relative affinity
of solenopsins for silicates and different solvents. Given this facile extraction procedure, copious
amounts of venom can be obtained from whole nests (further details are given in Fox et al. [84]).
Female individuals of any given caste will carry a unique mixture of solenopsins [130], as shown in
Figure 3. Unfortunately, because of the shared chemical properties between the different isomers,
complete purification of each of these compounds is currently not feasible [160]. Thus, until preparative
purification methods to separate isomers are devised, the study of the biological and physiological
effects of solenopsins depends either on the synthesis of each compound, or testing with natural mixed
extracts (see Fox [20]).
5.2.2. Solenopsin Pharmacology
In general, solenopsins are regarded as the main toxic component of fire ant venoms. Apart
from a burning sensation, oedema and pustule formation, they have been found to possess necrotic,
haemolytic, antibiotic, and insecticidal activities [23,153]. Many alkaloids have antimicrobial properties
to prevent infections from materials and prey brought into the colony. Solenopsins, in general, are no
exception with potent antimicrobial activity against fungi and gram-positive bacteria [161,162], while
solenopsin A was effective against gram-negative bacteria. The ants appear to employ this activity to
disinfect their surroundings and brood by vigorously shaking their gaster and spreading the venom
throughout the nest [163,164]. Also, solenopsins are effective as insect repellents and as insecticides,
mainly against lepidopterans [165,166]. Such a property is invaluable to these ants since they are
aggressive predators and competitors of other ants compared to thief ants which invade the nests of
other ants to pillage resources and the brood.
In mammals, solenopsins were demonstrated to cause a number of complex physiological
alterations, such as blockade of the neuromuscular junction [167], triggering histamine production
in mastocytes [168], inhibiting ATP-dependent sodium-potassium pumps, and respiratory
chains [169,170], activating platelets and neutrophils [171], and inhibiting neuronal nitric oxide
synthase [172]. Following intravenous injection, synthetic isosolenopsin A and solenopsin A were
capable of severely impairing both the central nervous system and cardiovascular systems of mice [173],
which shows their capacity to cross the blood-brain barrier. Doses of 3–30 mg/kg were particularly
toxic, causing a range of effects from dizziness, cardiorespiratory complications, seizures, and
death [173]. These toxic effects are beneficial to these ants as active predators of both vertebrate
and invertebrate prey, and also in defending their nests. Synthetic solenopsin A has been shown
to possess a potent inhibitory activity against class-1 phosphatidylinositol-3-kinase signalling and
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angiogenesis in mice embryos and zebra fish, making this alkaloid a potential lead therapeutic for the
treatment of cancer [174].
6. Other Toxins
A set of additional small molecule compounds have been found in ant venoms. This includes alkylated
pyrazines that are usually not considered alkaloids [127], being more common as mandibular gland
secretions, identified as venom components in some ants (e.g., Atta bisphaerica) [152,175]. The venom
glands of some species have also been reported to contain monoterpene hydrocarbons. For example,
the primary venom compound of Myrmicaria natalensis is the cyclic terpene limonene [176], however,
the venom also contains α-pinene, β-pinene, sabinene, terpinolene, β-myrcene, α-phallendrene,
α-terpinene, and caphene [177]. All of these compounds can be highly toxic to insects minding the
fact that this ant species preys on termites. The presence of immunologically active heterogeneous
polyanonic polysaccharides have also been reported in the venoms of Pseudomyrmex spp. [178]. There
are also non-alkaloidal amines such as pteridines that have been identified from some ants including
Formica and Lasius, actidines found in Megaponera and Dorymyrmex, and histamine which is abundant
in venoms of Myrmecia spp. [131,179].
Finally, it should be mentioned that the secreted venom of ants is even more complex due to
interactions with secretions from their Dufour1s gland. The Dufour1s gland is an accessory organ
attached to the venom gland and considered part of the venom apparatus [180]. Its secretions may
act synergistically with toxins originating from the venom gland and contribute to the toxicity of the
secreted venom. For example, the Dufour1s gland of Crematogaster scutellaris produces long-chain
primary acetates (non-toxic) which are converted to highly electrophilic aldehydes (toxic) by enzymes
from the venom gland during the venom secretion [181].
7. Conclusions
A host of recent studies have revealed that ant venoms are more complex and heterogeneous
than initially thought, owing in particular to the newly uncovered complexity of their peptidome
and proteome contents. Although the extant biodiversity of ant venoms remains largely unexplored,
their high plasticity is suggested by recent studies of a variety of subfamilies or genera, showing
highly different venom compositions. Formicinae ants and some Myrmicinae genera essentially
produce non-proteinaceous venoms primarily composed of formic acid and alkaloids, respectively. In
contrast, most ant species from other subfamilies have retained the ability to sting and, in turn, produce
peptide- and protein-rich venoms. Evolution has therefore led to some ants abandoning their ability to
sting, unlike wasps and most Apidae, whilst evolving a different set of chemical defenses along with
modified predatory and defensive behaviours. To date, the molecular and structural complexity of
ant venoms has barely been explored but the broad ecological diversity of ants strongly suggests that
further structural peptide and protein diversity might be uncovered by extensive biochemical studies,
leading to discovery of a much broader range of toxins than currently observed. Technological progress,
particularly in deep-sequencing approaches, coupled with high-end transcriptomic, peptidomic, and
enzymatic methods based on mass spectrometry and peptide de novo sequencing, will quickly allow
for the detection and characterization of numerous novel peptides and enzymes, at sensitivity levels
and a depth not previously attained. Despite the biochemical diversity potentially present in ant
venoms, this review highlights the paucity of knowledge on the molecular pharmacology of most
ant toxins. The biological function and mechanism of action of the majority of ant venom toxins
described to date remain poorly characterized or simply unstudied. Thorough exploration of a broader
taxonomic diversity will likely result in the discovery of novel bioactive toxins which may become
useful tools for biopesticide or drug development and will shed insights on the molecular evolution of
venom in Hymenoptera, the roles of venom in ant biology, the genetic makeup leading to ant venom
diversification and its role in the successful conquest of almost all ecological niches by ants. The
characterization of functional roles and pharmacological properties of this vast array of novel toxins
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(particularly peptides) will certainly become one of the most functional and significant endeavors in
future ant venom research, with a high application potential. Thus, the whole world of ant venom is
still a vast uncharted scientific territory awaiting our attention.
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